NCT05797415
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
- Locations
-
- Gustavo Savino Roma, Rome, Italy
Clinical trial condition
Carcinoma, Merkel Cell
Explore clinical trials studying Carcinoma, Merkel Cell. Study availability and eligibility vary by location and protocol.
106 public trials
31 recruiting studies
Carcinoma, Merkel Cell trial results
Not yet recruiting
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
NCT07576725
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
- Locations
-
- Uganda Cancer Institute Kampala, Uganda
Not yet recruiting
ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
NCT07472322
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
- Locations
-
- University of Wisconsin-Carbone Cancer Center Madison, Wisconsin, United States
NCT06448611
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +19 more
- Locations
-
Not specified
Not yet recruiting
Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC)
NCT06086288
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
- AOUS Policlinico Le Scotte Siena, Italy
- Azienda Ospedaliera Universitaria Integrata (AOUI) Verona, Italy
Not yet recruiting
Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns
NCT06039033
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Power Life Sciences San Francisco, California, United States
Active, not recruiting
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
NCT05358938
- Conditions
- Adenocarcinoma, Behavior, Carcinoma, +24 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Active, not recruiting
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
NCT03074513
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +63 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma
NCT04047251
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
- Locations
-
- HonorHealth Scottsdale, Arizona, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Dana Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
- Icahn School of Medicine at Mount Sinai New York, United States
Active, not recruiting
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
NCT02978625
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States